A highly selective, cell-permeable, and reversible protein kinase C (PKC) inhibitor (K
i = 10 nM) that is structurally similar to staurosporine. Acts as a competitive inhibitor for the ATP-binding site of PKC. Shows high selectivity for PKCα-, β
I-, β
II-, γ-, δ-, and ε- isozymes. Potently inhibits GSK-3 in primary adipocyte lysates (IC
50 = 360 nM) and in GSK-3β immunoprecipitates (IC
50 = 170 nM). May inhibit protein kinase A at a much higher concentration (K
i = 2 µM). A 1 mg/ml solution of Bisindolylmaleimide I (
Cat. No. 203293) in anhydrous DMSO is also available.
|
Product information
|
|
Form
|
Deep orange solid
|
|
Primary Target
|
PKC
|
|
Secondary target
|
GSK-3 (IC50 = 360 nM), GSK-3β (IC50 = 170 nM), PKA (Ki = 2 mM)
|
|
Molar mass
|
412.5
|
|
Protect from Light
|
Yes
|
|
Cell permeable
|
Yes
|
|
Reversible
|
Yes
|
|
Purity
|
≥95% by HPLC
|
|
Solubility
|
DMSO
|
|
Chemical formula
|
C25H24N4O2
|
|
CAS number
|
133052-90-1
|
|
Declaration
|
Sold under license of U.S. Patent 5,380,746.
|
|
Store and ship information
|
|
|
|
Storage
|
+2°C to +8°C
|
|
Ship
|
Ambient Temperature Only
Standard Handling
|